"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 6 | 6 | 12 |
| 1998 | 10 | 7 | 17 |
| 1999 | 15 | 2 | 17 |
| 2000 | 16 | 4 | 20 |
| 2001 | 15 | 1 | 16 |
| 2002 | 20 | 6 | 26 |
| 2003 | 35 | 8 | 43 |
| 2004 | 30 | 20 | 50 |
| 2005 | 35 | 10 | 45 |
| 2006 | 38 | 13 | 51 |
| 2007 | 32 | 13 | 45 |
| 2008 | 42 | 12 | 54 |
| 2009 | 41 | 12 | 53 |
| 2010 | 45 | 25 | 70 |
| 2011 | 60 | 24 | 84 |
| 2012 | 67 | 23 | 90 |
| 2013 | 89 | 42 | 131 |
| 2014 | 59 | 26 | 85 |
| 2015 | 61 | 26 | 87 |
| 2016 | 51 | 26 | 77 |
| 2017 | 66 | 22 | 88 |
| 2018 | 46 | 19 | 65 |
| 2019 | 42 | 18 | 60 |
| 2020 | 42 | 34 | 76 |
| 2021 | 35 | 48 | 83 |
| 2022 | 12 | 58 | 70 |
| 2023 | 16 | 52 | 68 |
| 2024 | 30 | 32 | 62 |
| 2025 | 38 | 12 | 50 |
| 2026 | 15 | 6 | 21 |
To return to the timeline,
click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Adverse effect of obesity and dysglycemia on bone microarchitecture and strength in youth: sex-related differences. J Clin Endocrinol Metab. 2026 Jul 15; 111(8):e1983-e1993.
-
Myeloid MMP14 couples extracellular proteolysis to inflammatory and metabolic remodeling during obesity. Cell Rep. 2026 Jul 28; 45(7):117681.
-
Insulin resistance and obesity: Drivers of energy crisis for Alzheimer's disease. Int Rev Neurobiol. 2026; 187:39-90.
-
2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026 Jul 28; 154(4):e50-e158.
-
Elecoglipron, an oral small molecule GLP-1 receptor agonist in adults with obesity or overweight (VISTA): a multicentre, phase 2, randomised, placebo-controlled clinical trial. Lancet. 2026 Jun 20; 407(10547):2503-2514.
-
Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2026 Aug; 32(8):2948-2958.
-
Associations among pork intake, weight-loss, and diet quality outcomes in a commercial weight-management program. Nutr Diabetes. 2026 05 29; 16(1).
-
Obesity in CKD: Core Curriculum 2026. Am J Kidney Dis. 2026 Jul; 88(1):142-153.
-
Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study. J Clin Endocrinol Metab. 2026 May 19; 111(6):1613-1627.
-
Selective and differential roles of PVHCRH neurotransmitters in diet-induced obesity in mice. Nat Commun. 2026 May 13; 17(1).